Skip to main content
Erschienen in: The Journal of Behavioral Health Services & Research 4/2009

01.10.2009 | Regular Article

Impact of Court-Mandated Substance Abuse Treatment on Clinical Decision Making

verfasst von: Noosha Niv, PhD, Alison Hamilton, PhD, Yih-Ing Hser, PhD

Erschienen in: The Journal of Behavioral Health Services & Research | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

California’s Proposition 36 offers nonviolent drug offenders community-based treatment as an alternative to incarceration or probation without treatment. The study objective was to examine how substance abuse treatment providers perceive the impact of Proposition 36 on their clinical decision making. Program surveys were completed by 115 treatment programs in five California counties to assess the impact of the law on clinical decision making, and five focus groups were conducted with 37 treatment providers to better understand their perspectives. Compared to residential programs, outpatient programs reported that the policy impacted them to a greater extent in terms of drug testing, reporting to criminal justice personnel, and determining client discharge. Providers in the focus groups particularly highlighted their changing roles in assessing clients’ treatment needs and determining the best routes of care for them. The findings indicate that alternate strategies for determining treatment placement and continuing care should be developed.
Fußnoten
1
Generally speaking, level 1 refers to education, level 2 to outpatient treatment, level 3 to intensive outpatient or day treatment, and level 4 to residential treatment. Considerable county-level variation exists with regard to the content of services within each level.
 
Literatur
1.
Zurück zum Zitat Hser YI, Maglione M, Joshi V, et al. Effects of treatment program and client characteristics on client treatment retention. Final report for the Center for Substance Abuse Treatment Office of Scientific Analysis and Evaluation Scientific Branch. Los Angeles, CA: University of California, Drug Abuse Research Center; 1998. Hser YI, Maglione M, Joshi V, et al. Effects of treatment program and client characteristics on client treatment retention. Final report for the Center for Substance Abuse Treatment Office of Scientific Analysis and Evaluation Scientific Branch. Los Angeles, CA: University of California, Drug Abuse Research Center; 1998.
2.
Zurück zum Zitat Hser YI, Teruya C, Brown AH, et al. Impact of California’s proposition 36 on the drug treatment system: Treatment capacity and displacement. The American Journal of Public Health. 2007;97:104–109.CrossRef Hser YI, Teruya C, Brown AH, et al. Impact of California’s proposition 36 on the drug treatment system: Treatment capacity and displacement. The American Journal of Public Health. 2007;97:104–109.CrossRef
4.
Zurück zum Zitat Hser YI, Teruya C, Evans EA, et al. Treating drug-abusing offenders. Initial findings from a five-county study on the impact of California’s proposition 36 on the treatment system and patient outcomes. Evaluation Review. 2003;27:479–505.PubMedCrossRef Hser YI, Teruya C, Evans EA, et al. Treating drug-abusing offenders. Initial findings from a five-county study on the impact of California’s proposition 36 on the treatment system and patient outcomes. Evaluation Review. 2003;27:479–505.PubMedCrossRef
5.
Zurück zum Zitat Craddock SG, Rounds-Bryant JL, Flynn PM, et al. Characteristics and pretreatment behaviors of clients entering drug abuse treatment: 1969 to 1993. American Journal of Drug and Alcohol Abuse. 1997;23(1):55–73.CrossRef Craddock SG, Rounds-Bryant JL, Flynn PM, et al. Characteristics and pretreatment behaviors of clients entering drug abuse treatment: 1969 to 1993. American Journal of Drug and Alcohol Abuse. 1997;23(1):55–73.CrossRef
6.
Zurück zum Zitat Farabee D, Prendergast M, Anglin MD. The effectiveness of coerced treatment for dug-abusing offenders. Federal Probation. 1998;62:3–10. Farabee D, Prendergast M, Anglin MD. The effectiveness of coerced treatment for dug-abusing offenders. Federal Probation. 1998;62:3–10.
7.
Zurück zum Zitat Marlowe DB. Integrating substance abuse treatment and criminal justice supervision. Science & Practice Perspectives. 2003;2:4–14. Marlowe DB. Integrating substance abuse treatment and criminal justice supervision. Science & Practice Perspectives. 2003;2:4–14.
8.
Zurück zum Zitat Speiglman R, Klein D, Miller R, et al. Early implementation of proposition 36: Criminal justice and treatment system issues in eight counties. Journal of Psychoactive Drugs. 2003;35:133–141.PubMed Speiglman R, Klein D, Miller R, et al. Early implementation of proposition 36: Criminal justice and treatment system issues in eight counties. Journal of Psychoactive Drugs. 2003;35:133–141.PubMed
9.
Zurück zum Zitat Taxman FS, Bouffard JA. The importance of systems issues in improving offender outcomes: Critical elements of treatment integrity. Justice Research & Policy. 2000;2:9–30. Taxman FS, Bouffard JA. The importance of systems issues in improving offender outcomes: Critical elements of treatment integrity. Justice Research & Policy. 2000;2:9–30.
10.
Zurück zum Zitat Taxman FS, Bouffard JA. Treatment inside the drug treatment court: The who, what, where, and how of treatment services. Substance Use & Misuse. 2002;37:1665–1688.CrossRef Taxman FS, Bouffard JA. Treatment inside the drug treatment court: The who, what, where, and how of treatment services. Substance Use & Misuse. 2002;37:1665–1688.CrossRef
11.
Zurück zum Zitat Klein D, Miller RE, Noble A, et al. Incorporating a public health approach in drug law: Lessons from local expansion of treatment capacity and access under California’s proposition 36. The Milbank Quarterly. 2004;82:723–757.PubMedCrossRef Klein D, Miller RE, Noble A, et al. Incorporating a public health approach in drug law: Lessons from local expansion of treatment capacity and access under California’s proposition 36. The Milbank Quarterly. 2004;82:723–757.PubMedCrossRef
12.
Zurück zum Zitat Gerstein DRE, Harwood HJE, eds. Treating Drug Problems, Volume 1: A Study of the Evolution, Effectiveness, and Financing of Public and Private Drug Treatment Systems. Washington, DC: National Academy Press; 1990. Gerstein DRE, Harwood HJE, eds. Treating Drug Problems, Volume 1: A Study of the Evolution, Effectiveness, and Financing of Public and Private Drug Treatment Systems. Washington, DC: National Academy Press; 1990.
13.
Zurück zum Zitat Ettner S, Huang D, Evans E, et al. Benefit-cost in the California treatment outcome project: Does substance abuse treatment “pay for itself”? Health Services Research. 2006;41:192–213.PubMedCrossRef Ettner S, Huang D, Evans E, et al. Benefit-cost in the California treatment outcome project: Does substance abuse treatment “pay for itself”? Health Services Research. 2006;41:192–213.PubMedCrossRef
14.
Zurück zum Zitat Sherman RK, Irvin LK, Yovanoff P, et al. federal demonstration funds at the interface of mental health and criminal justice. Administration and Policy in Mental Health. 2004;32:17–29.PubMedCrossRef Sherman RK, Irvin LK, Yovanoff P, et al. federal demonstration funds at the interface of mental health and criminal justice. Administration and Policy in Mental Health. 2004;32:17–29.PubMedCrossRef
15.
Zurück zum Zitat Taxman FS, Bouffard JA. Substance abuse counselors’ treatment philosophy and the content of treatment services provided to offenders in drug court programs. Journal of Substance Abuse Treatment. 2003;25:75–84.PubMedCrossRef Taxman FS, Bouffard JA. Substance abuse counselors’ treatment philosophy and the content of treatment services provided to offenders in drug court programs. Journal of Substance Abuse Treatment. 2003;25:75–84.PubMedCrossRef
16.
Zurück zum Zitat Barreira P, Espey B, Fishbein R, et al. Linking substance abuse and serious mental illness service delivery systems: Initiating a statewide collaborative. Journal of Behavioral Health Services Research. 2000;27:107–113.PubMedCrossRef Barreira P, Espey B, Fishbein R, et al. Linking substance abuse and serious mental illness service delivery systems: Initiating a statewide collaborative. Journal of Behavioral Health Services Research. 2000;27:107–113.PubMedCrossRef
17.
Zurück zum Zitat Grella CE, Gil-Rivas V, Cooper L. Perceptions of mental health and substance abuse program administrators and staff on service delivery to persons with co-occurring substance abuse and mental disorders. Journal of Behavioral Health Services Research. 2004;31:38–49.PubMedCrossRef Grella CE, Gil-Rivas V, Cooper L. Perceptions of mental health and substance abuse program administrators and staff on service delivery to persons with co-occurring substance abuse and mental disorders. Journal of Behavioral Health Services Research. 2004;31:38–49.PubMedCrossRef
18.
Zurück zum Zitat Grudzinskas Jr AJ, Clayfield JC, Roy-Bujnowski K, Fisher WH, et al. Integrating the criminal justice system into mental health service delivery: The Worcester diversion experience. Behavioral Sciences & the Law. 2005;23:277–293.CrossRef Grudzinskas Jr AJ, Clayfield JC, Roy-Bujnowski K, Fisher WH, et al. Integrating the criminal justice system into mental health service delivery: The Worcester diversion experience. Behavioral Sciences & the Law. 2005;23:277–293.CrossRef
Metadaten
Titel
Impact of Court-Mandated Substance Abuse Treatment on Clinical Decision Making
verfasst von
Noosha Niv, PhD
Alison Hamilton, PhD
Yih-Ing Hser, PhD
Publikationsdatum
01.10.2009
Verlag
Springer US
Erschienen in
The Journal of Behavioral Health Services & Research / Ausgabe 4/2009
Print ISSN: 1094-3412
Elektronische ISSN: 2168-6793
DOI
https://doi.org/10.1007/s11414-008-9129-z

Weitere Artikel der Ausgabe 4/2009

The Journal of Behavioral Health Services & Research 4/2009 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.